DSIJ Mindshare

Alembic Pharma gains on successful USFDA inspection of manufacturing unit

DSIJ Intelligence 0 1267 Article rating: No rating

Pharmaceutical major Alembic Pharma surged by over 5 per cent in Tuesday’s trade session on the back of successful USFDA inspection of its Panelav facility. The inspection by the United States Food and Drug Association concluded with zero Form 483s observations.

RSS
First74007401740274037405740774087409Last
DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR